INTEGRATED NON-CLINICAL AND CLINICAL RISK ASSESSMENT TO OBVIATE THE NEED FOR A DEDICATED QTC STUDY OF IXAZOMIB IN CANCER PATIENTS.
CLINICAL PHARMACOLOGY & THERAPEUTICS（2016）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined